Nafcillin Injection, Solution
Product Images NDC 0338-1019

4 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nafcillin (NDC 0338-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of nafcillin sodium shown as a molecular diagram, including its beta-lactam ring and associated functional groups, with the sodium (Na) and water molecule (H2O) indicated.*
FDA Label Image

Representative Container Label 0338-1019-48 (Image 02)

Representative Container Label 0338-1019-48 (Image 02)
Nafcillin Injection, USP 1 g in 50 mL single dose container by Baxter Healthcare Corporation, labeled as iso-osmotic and sterile nonpyrogenic. The label includes storage instructions, dosage information for intravenous administration, and warnings against freezing and reuse. NDC 0338-1017-41 and code 2G3540 are visible on the label. Made in USA.*
FDA Label Image

Representative Carton Label 0338-1019-48 Panel 1 Of 2 (Image 03)

Representative Carton Label 0338-1019-48 Panel 1 Of 2 (Image 03)
Nafcillin Injection, USP 1 g single-dose container, labeled for storage at or below 20°C (68°F) with warnings against thawing by immersion in water baths or microwave irradiation. The label shows it is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA.*
FDA Label Image

Representative Carton Label 0338-1019-48 Panel 2 Of 2 (Image 04)

Representative Carton Label 0338-1019-48 Panel 2 Of 2 (Image 04)
Drug facts text panels for Nafcillin Sodium Injection, 2 g/100 mL, in GALAXY Container by Baxter Healthcare Corporation. Each 50 mL contains Nafcillin Sodium USP equivalent to 1 g Nafcillin, plus Dexrose Hydrous and other buffers. Instructions indicate intravenous administration by physician, with cautions on usage and leak checks. Label states sterility and nonpyrogenic status and mentions Rx only use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.